CoChat

Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double‐blind controlled study in general practice

Nguyen, N., Fakra, E., Pradel, V., Jouve, E., Alquier, C., Le Guern, M‐E., Micallef, J., Blin, O. · 2006 · Human Psychopharmacology: Clinical and Experimental
Cited by 143

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Adjustment Disorders With Anxiety (ADWA) account for almost 10% of psychologically motivated consultations in primary care. The aim of this double‐blind randomised parallel group study was to compare (non‐inferiority test) the efficacies of etifoxine, a non‐benzodiazepine anxiolytic drug, and lorazepam, a benzodiazepine, for ADWA outpatients followed by general practitioners. 191 outpatients (mean age: 43, female: 66%) were assigned to receive etifoxine (50 mg tid) or lorazepam (0.5‐0.5‐1 mg /day) for 28 days. Efficacy was evaluated on days 7 and 28 of the treatment. The main efficacy assessment criterion was the Hamilton Rating Scale for Anxiety score (HAM‐A) on Day 28 adjusted to Day 0. The anxiolytic effect of etifoxine was found not inferior to that of lorazepam (HAM‐A score decrease: 54.6% vs 52.3%, respectively, p = 0.0006). The two drugs were equivalent on Day 28. However, more etifoxine recipients responded to the treatment (HAM‐A score decreased by ≥50%, p = 0.03). Clinical improvement (based on Clinical Global Impression scale CGI, Social Adjustment Scale Self‐Report SAS‐SR, and Sheehan scores) was observed in both treatment arms, but more etifoxine patients improved markedly (p = 0.03) and had a marked therapeutic effect without side effects as assessed by CGI, p = 0.04. Moreover, 1 week after stopping treatment, fewer patients taking etifoxine experienced a rebound of anxiety, compared to lorazepam (1 and 8, respectively, p = 0.034). Copyright © 2006 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.757

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 143

Metadata

Authors
Nguyen, N., Fakra, E., Pradel, V., Jouve, E., Alquier, C., Le Guern, M., Micallef, J., & Blin, O.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2006-04
Volume
21
Issue
3
Pages
139-149
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W1993909146
Cited by
143
References
12
FWCI
6.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.